Literature DB >> 26637113

Effect of Timing of Proton Pump Inhibitor Administration on Acid Suppression.

Kenji Furuta1, Kyoichi Adachi, Masahito Aimi, Shino Shimura, Hironobu Mikami, Nobuhiro Nishimura, Norihisa Ishimura, Shunji Ishihara, Kohji Naora, Yoshikazu Kinoshita.   

Abstract

BACKGROUND: Esomeprazole has been reported to show a strong acid suppression following preprandial as compared to postprandial administration, though no known study has compared the acid suppressing effects of other proton pump inhibitors between those administrations. The aim of this study was to compare intragastric pH levels following pre- and postprandial administrations of rabeprazole and esomeprazole.
METHODS: In 15 Helicobacter pylori-negative healthy volunteers, we measured intragastric pH after 7 days of pre- and postprandial administrations of rabeprazole (10 mg) or esomeprazole (20 mg) using a 5-way crossover design.
RESULTS: Preprandial administration of esomeprazole showed stronger acid suppression than postprandial administration. The values for percent time at pH >4.0 over a 24-hour period increased from 45.3% with postprandial administration of esomeprazole to 54.4% with preprandial administration, while the percent time at pH >4.0 during daytime was increased to a greater extent from 51.4 to 66.5% with preprandial administration (p = 0.05). On the other hand, the acid suppressing effect of rabeprazole was not influenced by the timing of administration.
CONCLUSIONS: The acid suppressing effect of esomeprazole is influenced by administration timing. In contrast, the acid suppressing effect of rabeprazole is not augmented by preprandial administration.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26637113     DOI: 10.1159/000441972

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.

Authors:  Yoshikazu Kinoshita; Mototsugu Kato; Mitsuhiro Fujishiro; Hironori Masuyama; Ryo Nakata; Hisanori Abe; Shinji Kumagai; Yasushi Fukushima; Yoshiumi Okubo; Seiichiro Hojo; Motoyasu Kusano
Journal:  J Gastroenterol       Date:  2017-11-29       Impact factor: 7.527

2.  Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention.

Authors:  Dongyoung Lee; Je Sang Kim; Beom Jin Kim; Seung Yong Shin; Dong Bin Kim; Hyung Sik Ahn
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

Review 3.  Effect of Food and Dosing Regimen on Safety and Efficacy of Proton Pump Inhibitors Therapy-A Literature Review.

Authors:  Agnieszka Wiesner; Małgorzata Zwolińska-Wcisło; Paweł Paśko
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.